Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Vaccine - Page 60

Vaccine

CDC published updated ACIP recommendations on the use of Td and Tdap vaccines
CDC | Disease | Non-Profit Research | Vaccine

CDC published updated ACIP recommendations on the use of Td and Tdap vaccines

On Jan. 24, 2020, the Centers for Disease Control and Prevention (CDC) published updated Immunization Practices Advisory Committee…

Read More CDC published updated ACIP recommendations on the use of Td and Tdap vaccinesContinue

World’s first meningitis B national infant vaccination programme showed 75% drop in cases over three years
Biotechnology | Therapeutics | Vaccine

World’s first meningitis B national infant vaccination programme showed 75% drop in cases over three years

On Jan. 23, 2020, two independent meningitis B studies were published in the New England Journal of Medicine…

Read More World’s first meningitis B national infant vaccination programme showed 75% drop in cases over three yearsContinue

Moderna announced funding award from CEPI to accelerate development of mRNA vaccine against novel Coronavirus
NIH | Non-Profit Research | Vaccine

Moderna announced funding award from CEPI to accelerate development of mRNA vaccine against novel Coronavirus

On Jan. 23, 2020, Moderna announced a new collaboration to develop an mRNA vaccine against the novel coronavirus…

Read More Moderna announced funding award from CEPI to accelerate development of mRNA vaccine against novel CoronavirusContinue

US DoD exercised option for IXIARO vaccine for Japanese encephalitis with Valneva
Biotechnology | FDA | Non-Profit Research | Therapeutics | Vaccine

US DoD exercised option for IXIARO vaccine for Japanese encephalitis with Valneva

On Jan. 14, 2020, Valneva announced that the U.S. Department of Defense (DoD) had exercised an option to…

Read More US DoD exercised option for IXIARO vaccine for Japanese encephalitis with ValnevaContinue

Sinovac announced approval of varicella vaccine for prevention of varicella/zoster virus (chickenpox) in children
Biotechnology | Vaccine

Sinovac announced approval of varicella vaccine for prevention of varicella/zoster virus (chickenpox) in children

On Dec. 27, 2019, Sinovac Biotech announced that the China National Medical Products Administration (NMPA) had approved and…

Read More Sinovac announced approval of varicella vaccine for prevention of varicella/zoster virus (chickenpox) in childrenContinue

Medigen Vaccine Biologics completed enrollment of phase III MRCT For EV71 vaccine
Disease | Vaccine

Medigen Vaccine Biologics completed enrollment of phase III MRCT For EV71 vaccine

On Dec. 25, 2019, Medigen Vaccine Biologics (MVB) announced it had completed the enrollment of phase III multi-region…

Read More Medigen Vaccine Biologics completed enrollment of phase III MRCT For EV71 vaccineContinue

New MERS Coronavirus vaccine clinical trial started in Saudi Arabia
Non-Profit Research | Vaccine

New MERS Coronavirus vaccine clinical trial started in Saudi Arabia

On Dec. 20, 2019, Vaccitech’s partner, the University of Oxford’s Jenner Institute, in collaboration with The King Abdullah…

Read More New MERS Coronavirus vaccine clinical trial started in Saudi ArabiaContinue

New pneumococcal vaccine from Serum Institute of India achieved WHO prequalification
Biotechnology | Vaccine | WHO

New pneumococcal vaccine from Serum Institute of India achieved WHO prequalification

On Dec. 19, 2019, the WHO announced that PNEUMOSIL, a vaccine against a leading cause of deadly childhood…

Read More New pneumococcal vaccine from Serum Institute of India achieved WHO prequalificationContinue

CDC published ACIP recommendations on the use of BioThrax
CDC | Non-Profit Research | Vaccine

CDC published ACIP recommendations on the use of BioThrax

On Dec. 13, 2019, the Centers for Disease Control and Prevention (CDC) published Immunization Practices Advisory Committee (ACIP)…

Read More CDC published ACIP recommendations on the use of BioThraxContinue

Seqirus’ Received Health Canada approval of first cell-based seasonal influenza vaccine
Biotechnology | Infectious Disease | Influenza | Vaccine

Seqirus’ Received Health Canada approval of first cell-based seasonal influenza vaccine

On Dec. 11, 2019, Seqirus announced that its cell-based quadrivalent influenza vaccine (QIVc) had received approval from Health…

Read More Seqirus’ Received Health Canada approval of first cell-based seasonal influenza vaccineContinue

CDC published updated ACIP recommendations for use of PCV13 and PPSV23 pneumococcal vaccines for adults age 65 and older
Biotechnology | CDC | FDA | NIH | Non-Profit Research | Pharmaceutical | Vaccine

CDC published updated ACIP recommendations for use of PCV13 and PPSV23 pneumococcal vaccines for adults age 65 and older

On Nov. 22, 2019, the Centers for Disease Control and Prevention”s (CDC) Advisory Committee on Immunization Practices (ACIP)…

Read More CDC published updated ACIP recommendations for use of PCV13 and PPSV23 pneumococcal vaccines for adults age 65 and olderContinue

Researchers at UGA’s Center for the Ecology of Infectious Diseases received a $16 million grant to study tropical diseases
Biotechnology | Disease | Therapeutics | Vaccine

Researchers at UGA’s Center for the Ecology of Infectious Diseases received a $16 million grant to study tropical diseases

On Oct. 30, 2019, researchers at the University of Georgia’s Center for the Ecology of Infectious Diseases received…

Read More Researchers at UGA’s Center for the Ecology of Infectious Diseases received a $16 million grant to study tropical diseasesContinue

New York State experienced measles outbreak
Biotechnology | Diagnostics | Measles | Therapeutics | Vaccine

New York State experienced measles outbreak

On Oct. 3, 2019, the New York State Department of Health announced that more than 42 days –…

Read More New York State experienced measles outbreakContinue

New York State declared measles free
Diagnostics | Measles | Non-Profit Research | Therapeutics | Vaccine

New York State declared measles free

On Oct. 3, 2019, the New York State Department of Health announced that more than 42 days –…

Read More New York State declared measles freeContinue

The NIH awarded up to $130 million over seven years for UGA to develop universal flu vaccine
Biotechnology | Influenza | Non-Profit Research | Therapeutics | Vaccine

The NIH awarded up to $130 million over seven years for UGA to develop universal flu vaccine

On Sept. 30, 2019, the University of Georgia (UGA) announced it had signed a contract with the National…

Read More The NIH awarded up to $130 million over seven years for UGA to develop universal flu vaccineContinue

Seattle Children’s received $30 million NIH funding to establish centers for TB vaccine development
Biotechnology | Infectious Disease | NIH | Non-Profit Research | Therapeutics | Vaccine

Seattle Children’s received $30 million NIH funding to establish centers for TB vaccine development

On Sept. 26, 2019, Seattle Children’s announced it was one of three recipients of $30 million in first-year-funding…

Read More Seattle Children’s received $30 million NIH funding to establish centers for TB vaccine developmentContinue

AAFP, AAP, ACHA, ACOG, APhA, SAHM, and IAC released “Dear Colleague” letter stressing importance of 16-year-old immunization visit
Biotechnology | Non-Profit Research | Vaccine

AAFP, AAP, ACHA, ACOG, APhA, SAHM, and IAC released “Dear Colleague” letter stressing importance of 16-year-old immunization visit

On Sept. 24, 2019, the American Academy of Family Physicians (AAFP), American Academy of Pediatrics (AAP), American College…

Read More AAFP, AAP, ACHA, ACOG, APhA, SAHM, and IAC released “Dear Colleague” letter stressing importance of 16-year-old immunization visitContinue

City of Port St Lucie Council voted to ᅠLeaseᅠ former VGTI Florida facility to the ᅠCleveland Clinic for $1  per year
Biotechnology | Disease | Non-Profit Research | Therapeutics | Vaccine

City of Port St Lucie Council voted to ᅠLeaseᅠ former VGTI Florida facility to the ᅠCleveland Clinic for $1 per year

On Aug. 26, 2019 , the City of Port St. Lucie Council voted 5 to 0 to ᅠleaseᅠ…

Read More City of Port St Lucie Council voted to ᅠLeaseᅠ former VGTI Florida facility to the ᅠCleveland Clinic for $1 per yearContinue

CDC released ACIP recommendations on use of influenza vaccines for the 2019-20 influenza season
Biotechnology | CDC | Infectious Disease | Influenza | Non-Profit Research | Vaccine

CDC released ACIP recommendations on use of influenza vaccines for the 2019-20 influenza season

On Aug. 23, 2019, the Centers for Disease Control and Prevention (CDC) released Immunization Practices Advisory Committee (ACIP)…

Read More CDC released ACIP recommendations on use of influenza vaccines for the 2019-20 influenza seasonContinue

CDC published updated ACIP recommendations for human papillomavirus vaccination of adults
Biotechnology | CDC | Disease | Non-Profit Research | Vaccine

CDC published updated ACIP recommendations for human papillomavirus vaccination of adults

On Aug. 16, 2019, the Centers for Disease Control and Prevention (CDC) published updated Immunization Practices Advisory Committee…

Read More CDC published updated ACIP recommendations for human papillomavirus vaccination of adultsContinue

CDC published ACIP recommendations on use of Japanese encephalitis vaccine
Biotechnology | CDC | Non-Profit Research | Therapeutics | Vaccine

CDC published ACIP recommendations on use of Japanese encephalitis vaccine

On Jul. 19, 2019, the Centers for Disease Control and Prevention (CDC) published recommendations from the Advisory Committee…

Read More CDC published ACIP recommendations on use of Japanese encephalitis vaccineContinue

Vanderbilt Vaccine Center Director James Crow Jr, MD, was awarded half of the Future Insight Prize by Merck KGaA of Germany
Biotechnology | Non-Profit Research | Vaccine

Vanderbilt Vaccine Center Director James Crow Jr, MD, was awarded half of the Future Insight Prize by Merck KGaA of Germany

On Jul. 9, 2019, Vanderbilt Vaccine Center announced that Director James Crow Jr., MD, had been awarded half…

Read More Vanderbilt Vaccine Center Director James Crow Jr, MD, was awarded half of the Future Insight Prize by Merck KGaA of GermanyContinue

CanSinoBIO received approval for Its 13-valent penumococcal conjugate vaccine to start clinical trials
Biotechnology | Therapeutics | Vaccine

CanSinoBIO received approval for Its 13-valent penumococcal conjugate vaccine to start clinical trials

On Jun. 20, 2019, CanSino Biologics announced that it had received the National Medical Products Administration’s (NMPA) permission…

Read More CanSinoBIO received approval for Its 13-valent penumococcal conjugate vaccine to start clinical trialsContinue

Winship Cancer Institute awarded prestigious Lung Cancer SPORE grant from NCI
Biotechnology | Diagnostics | Disease | Oncology | Radiology | Vaccine

Winship Cancer Institute awarded prestigious Lung Cancer SPORE grant from NCI

On Jun. 10, 2019, the Winship Cancer Institute was awarded a five-year, $9.7 million Specialized Program of Research…

Read More Winship Cancer Institute awarded prestigious Lung Cancer SPORE grant from NCIContinue

Vaccitech universal flu vaccine passed Phase 2b clinical development milestones
Biotechnology | Influenza | Therapeutics | Vaccine

Vaccitech universal flu vaccine passed Phase 2b clinical development milestones

On Jun. 5, 2019, Vaccitech announced that it has administered its pandemic universal influenza A vaccine MVA-NP+M1 (VTP-100)…

Read More Vaccitech universal flu vaccine passed Phase 2b clinical development milestonesContinue

UGA researchers discovered a vaccine for Crimean-Congo Hemorrhagic Fever (CCHF) virus
Biotechnology | Non-Profit Research | Therapeutics | Vaccine

UGA researchers discovered a vaccine for Crimean-Congo Hemorrhagic Fever (CCHF) virus

On Apr. 25, 2019, researchers at the University of Georgia announced they had successfully discovered a single-dose vaccine…

Read More UGA researchers discovered a vaccine for Crimean-Congo Hemorrhagic Fever (CCHF) virusContinue

GSK invested $100 million to expand long-term vaccine manufacturing capabilities in Hamilton
Biotechnology | FDA | Infectious Disease | Vaccine

GSK invested $100 million to expand long-term vaccine manufacturing capabilities in Hamilton

On Apr. 24, 2019, GSK announced $100 million of new investment in its manufacturing site in Hamilton, Montana…

Read More GSK invested $100 million to expand long-term vaccine manufacturing capabilities in HamiltonContinue

Sinovac announced positive results from phase III trial of a Sabin strain-based inactivated Polio vaccine (sIPV) were published
Biotechnology | Infectious Disease | Polio | Vaccine

Sinovac announced positive results from phase III trial of a Sabin strain-based inactivated Polio vaccine (sIPV) were published

On Apr. 16, 2019, Sinovac Biotech announced that the positive results from the Company’s Phase III clinical study…

Read More Sinovac announced positive results from phase III trial of a Sabin strain-based inactivated Polio vaccine (sIPV) were publishedContinue

CDC published ACIP recommendations for use of hepatitis A vaccine for persons experiencing homelessness
Biotechnology | CDC | Vaccine

CDC published ACIP recommendations for use of hepatitis A vaccine for persons experiencing homelessness

On Feb. 15, 2019, the U.S. Centers for Disease Control and Prevention (CDC) published ACIP recommendations for use….

Read More CDC published ACIP recommendations for use of hepatitis A vaccine for persons experiencing homelessnessContinue

FDA approved use of the 05 mL dose of Sanofi’s Fluzone Quadrivalent influenza vaccine to include children age 6 through 35 months
Biotechnology | Influenza | Pharmaceutical | Vaccine

FDA approved use of the 05 mL dose of Sanofi’s Fluzone Quadrivalent influenza vaccine to include children age 6 through 35 months

On Jan. 23, 2019, U.S. Food and Drug Administration (FDA) announced it had approved approved the use of…

Read More FDA approved use of the 05 mL dose of Sanofi’s Fluzone Quadrivalent influenza vaccine to include children age 6 through 35 monthsContinue

Page navigation

Previous PagePrevious 1 … 58 59 60 61 62 … 76 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search